Quality of Life, Blood Transfusions, and Toxicity, in Anemic Patients with Advanced Cancer Receiving Weekly Erythropoietin While on Chemotherapy: Results from a Phase III Randomized Double-Blind Placebo-Controlled Study.
Reviewer: Ryan Smith, MD
Ultima Vez Modificado: 7 de diciembre del 2002
Translation for this article does not exist
KeywordsClick on any of these terms for more related articles
May 12, 2015
July 21, 2016